These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8480357)

  • 21. Characteristics and frequency of DEL phenotype detected by indirect antiglobulin test in Dalmatia county of Croatia.
    Dajak S; Krstic JL; Körmöczi G; Dogic V; Burilovic V
    Transfus Apher Sci; 2014 Apr; 50(2):210-3. PubMed ID: 24556127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary anti-D immunization by DEL red blood cells.
    Kim KH; Kim KE; Woo KS; Han JY; Kim JM; Park KU
    Korean J Lab Med; 2009 Aug; 29(4):361-5. PubMed ID: 19726900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management.
    McGowan EC; Lopez GH; Knauth CM; Liew YW; Condon JA; Ramadi L; Parsons K; Turner EM; Flower RL; Hyland CA
    Vox Sang; 2017 Apr; 112(3):279-287. PubMed ID: 28220510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incidence of weak D antigens (Du) of the Rh system in blood donors].
    Blicharczyk-Sypek B; Frankowska K
    Pol Tyg Lek; 1968 Jan; 23(3):89-90. PubMed ID: 4967831
    [No Abstract]   [Full Text] [Related]  

  • 25. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors.
    Luettringhaus TA; Cho D; Ryang DW; Flegel WA
    Transfusion; 2006 Dec; 46(12):2128-37. PubMed ID: 17176325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phenotype Types and Genetic Mutation Mechanism of Rhesus D Variant Individuals].
    Luo H; Wen JZ; Zhang RQ; Ji YL; Mo CY; Wei L; Wang Z; Liao ZJ; Luo GP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1804-1809. PubMed ID: 29262920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria.
    Polin H; Danzer M; Gaszner W; Broda D; St-Louis M; Pröll J; Hofer K; Gabriel C
    Transfusion; 2009 Apr; 49(4):676-81. PubMed ID: 19170995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the applicability and effectiveness of a molecular strategy for identifying weak D and DEL phenotype among D- blood donors of mixed origin exhibiting high frequency of RHD*Ψ.
    Dezan MR; Guardalini LGO; Pessoa E; Ribeiro IH; Oliveira VB; Luz F; Novac DR; Gallucci A; Bonifácio S; Gomes F; Levi JE; Pereira AC; Krieger JE; Mendrone-Junior A; Rocha V; Dinardo CL
    Transfusion; 2018 Feb; 58(2):317-322. PubMed ID: 29193119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes.
    Cruz BR; Chiba AK; Moritz E; Bordin JO
    Transfus Med; 2012 Apr; 22(2):84-9. PubMed ID: 22211984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outliers in RhD membrane integration are explained by variant RH haplotypes.
    Yu X; Wagner FF; Witter B; Flegel WA
    Transfusion; 2006 Aug; 46(8):1343-51. PubMed ID: 16934070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program.
    Vege S; Westhoff CM
    Immunohematology; 2006; 22(3):143-7. PubMed ID: 17105364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RHD variants in Flanders, Belgium.
    Van Sandt VS; Gassner C; Emonds MP; Legler TJ; Mahieu S; Körmöczi GF
    Transfusion; 2015 Jun; 55(6 Pt 2):1411-7. PubMed ID: 25413499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FPTT is a low-incidence Rh antigen associated with a "new" partial Rh D phenotype, DFR.
    Lomas C; Grässmann W; Ford D; Watt J; Gooch A; Jones J; Beolet M; Stern D; Wallace M; Tippett P
    Transfusion; 1994 Jul; 34(7):612-6. PubMed ID: 7519797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Rh phenotype on the antigen density of C, c, and D: flow cytometric study using a frozen standard red cell.
    Wagner FF
    Transfusion; 1994 Aug; 34(8):671-6. PubMed ID: 8073482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How I manage donors and patients with a weak D phenotype.
    Flegel WA
    Curr Opin Hematol; 2006 Nov; 13(6):476-83. PubMed ID: 17053462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
    Credidio DC; Pellegrino J; Castilho L
    Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RHD positive among C/E+ and D- blood donors in Denmark.
    Christiansen M; Sørensen BS; Grunnet N
    Transfusion; 2010 Jul; 50(7):1460-4. PubMed ID: 20456676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RHD/CE typing by polymerase chain reaction using sequence-specific primers.
    Gassner C; Schmarda A; Kilga-Nogler S; Jenny-Feldkircher B; Rainer E; Müller TH; Wagner FF; Flegel WA; Schönitzer D
    Transfusion; 1997 Oct; 37(10):1020-6. PubMed ID: 9354819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The occurrence of weak D antigens (Du) of the Rh system in blood donors.
    Blicharczyk-Sypek B; Frankowska K
    Pol Med J; 1968; 7(6):1335-7. PubMed ID: 4976046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.